SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-063134
Filing Date
2023-11-13
Accepted
2023-11-13 17:25:47
Documents
12
Period of Report
2023-11-10
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K crbp-20231110.htm   iXBRL 8-K 52459
  Complete submission text file 0000950170-23-063134.txt   171347

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbp-20231110.xsd EX-101.SCH 2469
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbp-20231110_pre.xml EX-101.PRE 9900
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbp-20231110_lab.xml EX-101.LAB 13474
6 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20231110_htm.xml XML 4767
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 231400182
SIC: 2834 Pharmaceutical Preparations